• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于当前 COVID-19 大流行的观点:使用功能性食品来增强我们的免疫功能。

Opinions on the current pandemic of COVID-19: Use functional food to boost our immune functions.

机构信息

Nimni-Cordoba Tissue Engineering and Drug Discovery Laboratory, Department of Surgery, University of Southern California, Los Angeles, CA 90033, United States.

Nimni-Cordoba Tissue Engineering and Drug Discovery Laboratory, Department of Surgery, University of Southern California, Los Angeles, CA 90033, United States.

出版信息

J Infect Public Health. 2020 Dec;13(12):1811-1817. doi: 10.1016/j.jiph.2020.08.014. Epub 2020 Sep 10.

DOI:10.1016/j.jiph.2020.08.014
PMID:32948484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7831995/
Abstract

The pandemic of novel coronavirus caused COVID-19 had resulted in a high number of hospitalizations and deaths and caused a devastating toll on human and society health. The symptoms of the infected patients vary significantly, from life-threatening to mild or even asymptomatic. This clinical observation led to hypothesize on the critical role of host innate immunity in the disease development and progression. As the first defense barrier against microorganisms, the innate immune reaction determines not only the viral infection rate but also immune-mediated response. Therefore, promote healthy behaviors to enhance innate immunity with functional food and nutritional agents may be a rational strategy for minimizing damages caused by viruses to global health.

摘要

新型冠状病毒引发的大流行导致 COVID-19 导致大量住院和死亡,对人类和社会健康造成了毁灭性的影响。感染患者的症状差异很大,从危及生命到轻微甚至无症状。这种临床观察导致人们假设宿主固有免疫在疾病发展和进展中起关键作用。作为抵御微生物的第一道防线,固有免疫反应不仅决定了病毒感染率,还决定了免疫介导的反应。因此,促进健康行为,利用功能性食品和营养剂增强固有免疫可能是减轻病毒对全球健康造成损害的合理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c840/7831995/0110da51b206/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c840/7831995/0110da51b206/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c840/7831995/0110da51b206/gr1_lrg.jpg

相似文献

1
Opinions on the current pandemic of COVID-19: Use functional food to boost our immune functions.关于当前 COVID-19 大流行的观点:使用功能性食品来增强我们的免疫功能。
J Infect Public Health. 2020 Dec;13(12):1811-1817. doi: 10.1016/j.jiph.2020.08.014. Epub 2020 Sep 10.
2
The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.SARS-CoV-2 与 COVID-19 免疫病理的免疫反应——当前观点。
Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9.
3
Targeted Application of Functional Foods as Immune Fitness Boosters in the Defense against Viral Infection.靶向应用功能性食品作为免疫增强剂,以抵御病毒感染。
Nutrients. 2023 Jul 28;15(15):3371. doi: 10.3390/nu15153371.
4
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.
5
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).新型冠状病毒(SARS-CoV-2)免疫反应综述。
Immunol Res. 2021 Jun;69(3):213-224. doi: 10.1007/s12026-021-09198-0. Epub 2021 Apr 29.
6
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
7
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.固有免疫和适应性免疫对 SARS-CoV-2 及相关影响因素。
Front Immunol. 2023 May 9;14:1159326. doi: 10.3389/fimmu.2023.1159326. eCollection 2023.
8
[Interaction between SARS-CoV-2 and Host Innate Immunity].[严重急性呼吸综合征冠状病毒2与宿主固有免疫之间的相互作用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Jan;53(1):1-6. doi: 10.12182/20220160101.
9
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.无症状、轻症和重症 SARS-CoV-2 感染者的固有和适应性免疫反应不同。
Front Immunol. 2020 Dec 16;11:610300. doi: 10.3389/fimmu.2020.610300. eCollection 2020.
10
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.冠状病毒感染和新冠肺炎期间天然免疫在保护及发病机制中的作用
Annu Rev Immunol. 2024 Jun;42(1):615-645. doi: 10.1146/annurev-immunol-083122-043545.

引用本文的文献

1
Goat Cheese Produced with Sunflower ( L.) Seed Extract and a Native Culture of : Characterization and Probiotic Survival.用向日葵(L.)种子提取物和一种本地培养物生产的山羊奶酪:特性与益生菌存活情况
Foods. 2024 Sep 13;13(18):2905. doi: 10.3390/foods13182905.
2
Trends and current food safety regulations and policies for functional foods and beverages containing botanicals.含植物成分的功能性食品和饮料的趋势及现行食品安全法规和政策。
J Food Drug Anal. 2024 Jun 15;32(2):112-139. doi: 10.38212/2224-6614.3499.
3
Functional Food Consumption and Its Associated Factors among University Students in Malaysia during COVID-19 Pandemic.

本文引用的文献

1
The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?先天性免疫系统:是在前线作战还是助长 COVID-19 的火势?
Cell Host Microbe. 2020 Jun 10;27(6):863-869. doi: 10.1016/j.chom.2020.05.009. Epub 2020 May 20.
2
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
3
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.
马来西亚大学生在新冠疫情期间的功能性食品消费及其相关因素
Malays J Med Sci. 2023 Dec;30(6):133-146. doi: 10.21315/mjms2023.30.6.13. Epub 2023 Dec 19.
4
A Prospective Study of AFree Oral Spray as an Adjuvant Therapy for Mild and Moderate COVID-19 in Community Health Stations: Clinical Progression and Viral Clearance Outcomes.一项在社区卫生服务站中使用 AFree 口腔喷雾作为轻度和中度 COVID-19 辅助治疗的前瞻性研究:临床进展和病毒清除结局。
In Vivo. 2023 Sep-Oct;37(5):2155-2160. doi: 10.21873/invivo.13313.
5
Therapeutic Efficacy of AFree Oral Spray on the Symptoms and Course of Moderate and Severe COVID-19 in the Field Hospital.野战医院中 AFree 口腔喷雾对中重度 COVID-19 症状和病程的治疗效果。
In Vivo. 2023 Jul-Aug;37(4):1743-1750. doi: 10.21873/invivo.13262.
6
The Impact of COVID-19 Pandemic on Seafood Safety and Human Health.新冠疫情对海鲜安全及人类健康的影响
Front Microbiol. 2022 Jun 22;13:875164. doi: 10.3389/fmicb.2022.875164. eCollection 2022.
7
Impact of Emulsifier Structure and Concentration on Lipolysis Dynamics and Curcumin Bioaccessibility in the Nanoemulsions Stabilized by Polyglycerol Fatty Acid Esters.乳化剂结构和浓度对聚甘油脂肪酸酯稳定的纳米乳液中脂肪分解动力学及姜黄素生物可及性的影响
Food Biophys. 2022;17(4):575-585. doi: 10.1007/s11483-021-09681-z. Epub 2022 May 24.
8
Functional food: complementary to fight against COVID-19.功能性食品:对抗新冠病毒的补充手段。
Beni Suef Univ J Basic Appl Sci. 2022;11(1):33. doi: 10.1186/s43088-022-00217-z. Epub 2022 Mar 7.
9
Enhanced γ-aminobutyric acid and sialic acid in fermented deer antler velvet and immune promoting effects.发酵鹿茸中γ-氨基丁酸和唾液酸含量增加及其免疫促进作用。
J Anim Sci Technol. 2022 Jan;64(1):166-182. doi: 10.5187/jast.2021.e132. Epub 2022 Jan 31.
10
Curcumin Extraction, Isolation, Quantification and Its Application in Functional Foods: A Review With a Focus on Immune Enhancement Activities and COVID-19.姜黄素的提取、分离、定量及其在功能性食品中的应用:以免疫增强活性和COVID-19为重点的综述
Front Nutr. 2021 Sep 21;8:747956. doi: 10.3389/fnut.2021.747956. eCollection 2021.
新冠病毒疾病在自然状态和免疫抑制状态下:一项临床治疗分期建议。
J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.
4
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
5
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.瑞德西韦治疗新型冠状病毒肺炎:证据评价。
Travel Med Infect Dis. 2020 May-Jun;35:101647. doi: 10.1016/j.tmaid.2020.101647. Epub 2020 Apr 2.
6
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
7
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
8
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
9
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒(2019 - 新冠病毒)。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
10
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.实时预测和预报源自中国武汉的 2019-nCoV 疫情在国内和国际的潜在传播:一项建模研究。
Lancet. 2020 Feb 29;395(10225):689-697. doi: 10.1016/S0140-6736(20)30260-9. Epub 2020 Jan 31.